Pharm - Diabetes Flashcards

(33 cards)

1
Q

renal failure, avoid

A

metformin (lactic acidosis)
glyburide
SGLT-2 inhib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF, avoid

A

thiazolidinediones (fluid retention)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biguanides

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sulfonylureas

A

(“insulin secretagogues”)

glyburide
glipizide
glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

meglitinides

A

(“insulin secretagogues”)

repaglinde
nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

thiazolidinediones

A

piglitazone

rosglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

glucosidase inhibitors

A

acarbose
miglitol
voglibose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

amylin analogs

A

pramlintide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GLP-1 analogs

A

exenatide

liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DPP-4 inhibitors

A

sitagliptin

linagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SGLT-2 inhibitors

A

canagliflozin

dapagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

metformin MOA

A

inhib glucagon, dec hepatic glucose prod
dec serum FFAs
reduced glucose absorption from GI
dir stim of glycolysis in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

metformin AE

A

GI upset

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sulfonylureas MOA

A

close K+ chan in B cell –> inc resting potential –> depolarization –> inc insulin release indep of [glucose]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sulfonylureas AE

A

hypOglycemia
weight gain
flushing
hypOnatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sulfonylurea drug that is high risk in elderly/poor renal function

17
Q

meglitinides MOA

A

close K+ chan in B cell –> inc resting potential –> depolarization –> inc insulin release indep of [glucose]

18
Q

meglitinides AE

19
Q

thiazolidinediones MOA

A

TZOs bind to PPAR-gamma r (m./liver/adipocytes) –> inc insulin sensitivity and inc adiponectin

20
Q

thiazolidinediones AE

A

weight gain

fluid retention

21
Q

glucosidase inhibitors MOA

A

compete with intestinal alpha-glucosidases which normally hydrolyze starches/oligo/disach –> slows absorption of glucose at distal SI

22
Q

glucosidase inhibitors AE

A

GI upset (diarrhea, flatulence)

23
Q

amylin analogs MOA

A

suppress glucagon release
delay gastric emptying
reduce appetite
–> insulin able to work more effectively

24
Q

amylin analogs AE

A

hypOglycemia

N/V/anorexia

25
GLP-1 analogs MOA
- stim insulin release | - blunts glucagon release --> slows gastric emptying
26
GLP-1 analogs AE
``` N/V/D acute pancreatitis (rare) ```
27
DPP-4 inhibitors MOA
dec inhibition of GIP/GLP release
28
DPP-4 inhibitors AE
urinary/resp infection | nasopharyngitis
29
SGLT-2 inhibitors MOA
inhib loss of glucose in urine at PCT
30
SGLT-2 inhibitors AE
vulvovaginal candidiasis UTIs hypOtn
31
rapid acting insulin onset/peak
lisper aspart glulisine ^insulin analogs o: 15 min p: 45-75 min
32
intermediate acting insulin onset/peak
regular insulin NPH insulin p: 4-10hr
33
long-acting insulin onset/peak
Glargine | Detemir